Bifidobacterium bifidum strain used to obtain bifido-containing product

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium bifidum 74-22 strain has acid-forming activity and antagonistic activity on pathogenic and opportunistic microorganisms, and is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 244.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

 

The invention relates to the food, cosmetic, biotech and medical industries, in particular, is used to prepare fermented milk, fermented and non-fermented food, hygiene and cosmetics, dietary supplements and bacterial preparations.

Due to unfavorable environmental conditions, stress, prolonged antibiotic, radiotherapy and chemotherapy, dysbiosis resulting from illness, an increasing number of people suffering from disorders of the normal microflora. For the treatment and prevention of these disorders is gaining attention as drugs, with probiotic action, and food products containing bifidobacteria.

In the human intestine, basically, there are 5 types of bacteria: B. bifidum, B. longum, B. adolescentis, B. breve, and B. infantis. Of them with the greatest frequency in the biocenosis detected species B. bifidum and B. longum. Species B. adolescentis is more common in adults, and species B.breve and B.infantis - predominantly in infants.

Well-known foreign mono - and combination preparations-eubiotics and dairy products, including bifidobacteria species B. bifidum, B. lonqum, B. adolescentis, B. breve (patent 2336886, patent 2411008, France; patent 637297, Switzerland; patent 2134179, Pat the NT 2421066, Germany; patent 05227946, patent 0430642, Japan; patent 4645667, U.S. patent 6063935, Japan, the patent 5922375, U.S. patent 5902743, U.S. patent 6746672, U.S. patent 6548057, USA). In our country for the preparation of bacterial preparations, dietary supplements, medicinal products-dietary use of domestic strains of Bifidobacterium species B. bifidum 1,791,792; B. lonqum B379M, I-2, I-4; B. adolescentis MC-42, G 7513; B. breve 79-119; B. infantis 79-43 (copyright certificate №343588, RF patent 1347221, RF patent 849779, RF patent 2108383, RF patent 2152993, patent 863639, RF patent 2120991, RF patent 2078814, RF patent 2111248).

The quality of medicinal products and drugs is largely due to the properties of the producer strain - specific activity and adaptability. A large range of biologically active and technologically advanced strains of bifidobacteria makes possible the development of new mono - and integrated products for medical nutrition and bakpreparatov, capable of providing high colonization resistance of the human intestine, to restore the normal microflora and reduce the incidence of various intestinal infections.

The present invention is to obtain a strain of microorganism of the species B.bifidum 74-22 with high biological activity, resistance to environmental conditions, with a stabilizing kislotoobrazovanie in the whole temperature range the development of cells, antagonistically active against pathogenic and conditionally pathogenic microorganisms proliferating on artificial nutrient media.

Strain Bifidobacterium bifidum 74-22 isolated from the contents of the intestines of healthy infant and deposited in the Public collections of the normal microflora (HCNM) fsri mniam them. Hingamisega of the CPS No. 244.

The inventive strain can be used in the production of dairy products, fermented foods, such as kvass, beer, etc., non-fermented foods, such as juices, drinks, etc., biologically active additives to food. Strain Bifidobacterium bifidum 74-22 can be widely used for the production of hygienic and cosmetic products such as creams, lotions, wipes, Soaps, powders, tampons, nourishing masks, gels, feminine sanitary pads, skin milk, various powders, etc.

In addition, the strain of Bifidobacterium bifidum 74-22 can be used in the production of bacterial preparations, in the form of candles, oral, and other tools.

The technical result of the claimed invention to provide a strain of Bifidobacterium bifidum 74-22, which can be used as biologically active substances in the composition of fermented milk, fermented and non-fermented food is Reducto, hygienic and cosmetic products, biologically active additives and bacterial preparations. Strain Bifidobacterium bifidum 74-22 has biologically and technologically important properties, such as high acid activity and its ability to increase microbial biomass in a short period of cultivation. Strain Bifidobacterium bifidum 74-22 antagonistically active against pathogenic and conditionally pathogenic microorganisms. This will allow the use of Bifidobacterium bifidum 74-22 as a biologically active component in the composition of different probiotic means of ensuring the normalization of microbiocenosis of the human body, including the gastrointestinal and urogenital tracts, skin and mucous membranes of the skin, and broaden the Arsenal of similar means.

Cultural and morphological properties of the strain.

Cells are gr+ polymorphic sticks with bifurcation or thickening 1-2 all, in a liquid nutrient medium to grow over the entire height of the volume, except for the zone of aerobiosis. Separately grown colonies on hepatic nutrient medium have an elongated form colonies. Logarithmic growth phase ends at 12-24 hours of cultivation.

Physical and biochemical properties of the strain.

Non-sporulating, still gone anaerobic. The optimum temperature for growing 38,0±0,5°C. Catalase does not form, gelatino not razzi the AET. Sprayway glucose with the formation of acetic and L + lactic acid, without the formation of gas, sakissa environment growing to a pH of 4.3-3,9.

Ferments lactose, fructose, galactose, sucrose. Not ferments sorbitol, arabinose, salicin, inulin, cellobiose, xylose, mannose, beckons. Strain Bifidobacterium bifidum 74-22 has an antagonistic activity against pathogenic and conditionally pathogenic microflora (table 1).

Table 1
Antagonistic activity of strain Century bifidum 74-22
StrainThe zone of growth inhibition of the test cultures mm/ M±t
Sh. sonnetSh. flexneriE. coliS. aureusPr. vulgaris
Century bifidum 74-2228±2,620±2,812±2,418±1,616±2.2

The strain is expanding microbial mass and increase hydrolysate-dairy medium (GM), Bifidum environment (BF), thus producing acid (table 2).

The accumulation of microbial biomass (CFU/ml lg 10 and the activity of acid generating ( in degrees Turner) strain B.bifidum 74-22 in the dynamics of development
NUTRIENT MEDIUMTIME CULTIVATING BIOLOGICAL ACTIVITY
12 hours24 hours48 h
SOMESOMESOME
GM7,6928,01067,0118
BF8,2869,41187,6134

The maximum strain accumulates microbial mass to 12-24 hours, reaching in 1 ml lg 8-9 microbial cells that are actively producing acid.

Thus, the proposed strain Century bifidum 74-22 tech, as propagated in different the x nutrient media with the accumulation of production of biomass with a high concentration of bifidobacteria; has acid-forming activity and antagonistic activity against pathogenic and conditionally pathogenic microorganisms.

Fermented milk, fermented, unfermented food, hygiene, cosmetics, dietary supplements and bacterial preparations containing strain Century bifidum 74-22, can be widely used in food, medical, biotechnology and cosmetic industries.

The ability of strain Century bifidum 74-22 to increase the biomass in the nutrient medium in a short period of cultivation, acid-forming activity, antagonistic activity against pathogenic and conditionally pathogenic microflora, as well as other useful for the human body properties, typical for the species C. bifidum, make possible the use of the strain in the various corrective means of therapeutic and prophylactic purposes.

Example 1. The use of strain Century bifidum 74-22 in the composition of dietary supplements.

1 passage: lyophilized strain Century bifidum 74-22 in an amount of 0.1 g dry biomass contribute in tubes with nutrient medium and titrated by the method of ten-fold dilutions up to 10-9. Incubated at a temperature 38,0±0.5°C prior to the formation of visible growth in the last dilutions.

2 passage: a grown culture of 10-7-9breeding in the volume is up 10% contribute to the nutrient medium and cultured at a temperature 38,0±0,5°C for 12-24 h before formation of the dense growth of the visible area of aerobiosis.

3 passage: the biomass in an amount up to 10% of the volume contribute to the accumulation and cultivate 12-24 h at 38,0±0.5°C, to obtain a biomass content of live bifidobacteria not less than 108/ml.

The result is biologically active additive, which is a liquid concentrate with a high, not less than 108/ml, content of bifidobacteria. When listening to concentrate with protective environments (saharso-gelatin medium, skim milk or other) get dry biologically active Supplement containing bifidobacteria not less than 107/ml.

Example 2. The use of strain Century bifidum 74-22 for the preparation of fermented and non-fermented foods.

1 passage: lyophilized strain Century bifidum 74-22 in an amount of 0.1 g dry biomass contribute in tubes with nutrient medium and titrated by the method of ten-fold dilutions up to 10-9. Incubated at 38,0±0.5°C prior to the formation of visible growth in the last dilutions.

2 passage: a grown culture of 10-7-9breeding up to 10% contribute to the nutrient medium and cultured at a temperature 38,0±0,5°C for 12-24 h before formation of dense growth with a highly visible area of aerobiosis.

3 passage: the biomass in an amount up to 10% of the volume contribute to the accumulation and cultivate 12-24 h at 38,0±0.5°C, to obtain a biomass content is of living bifidobacteria not less than 10 8/ml.

Obtaining a fermented or non-fermented food: grown biomass bring in food raw materials (milk, juices, beer, kvass, etc. up to 10% of the volume, mix and pour into containers. The result is a product with a concentration of live bifidobacteria not less than 106/ml.

Example 3. The use of strain Century bifidum 74-22 for the preparation of a fermented milk product.

1 passage: lyophilized strain introduced into the environment of cultivation and titrated by the method of ten-fold dilutions up to 10-9. Incubated at 38,0±0.5°C prior to the formation of visible growth in the last dilutions. Or dry lyophilized biomass of bifidobacteria contribute in 1-2 doses in the tube with 30 ml of culture medium. Cultivated at a temperature 38,0±0.5°C, to obtain a biomass content of live bifidobacteria not less than 107/ml.

2 passage: a grown culture of strain Century bifidum 74-22 of the last dilution or test-tube with the increased biomass contribute to the accumulation of up to 10% and cultured at a temperature 38,0±0.5°C, to obtain a biomass containing bifidobacteria not less than 108/ml.

3 passage: the biomass of the strain Century bifidum 74-22 (passage No. 2) enter in the composition of the fermented milk product in the amount of 5-10% by volume, getting in the finished product bifidobacteria not less than 106-7/ml. Quantity p is Saga No. 2 may be increased depending on the volume of production.

Example 4. The use of strain Century bifidum 74-22 to obtain bacterial preparations.

The culture of the strain of the 1st or 2nd passage (example No. 1) contribute to the nutrient medium, cultured at a temperature 38,0±0,5°C to obtain the biomass of bifidobacteria with the contents of living cells is not less than 108in 1 ml. To the obtained biomass add a protective environment drying (saharso-gelatin medium, skim milk). The resulting suspension is poured into ampoules, vials and other containers, frozen at minus 35-45°C and lyophilizers from the frozen state in a vacuum drying apparatus. The resulting preparation contains not less than 107living cells of bifidobacteria. The content of bifidobacteria is consistent with the scientific and technical documentation on similar bifidobakterii drug "Bifidumbacterin dry" and is sufficient to use the funds received as a drug - eubiotics.

Example 5. The use of Bifidobacterium bifidum 74-22 to get hygienic and cosmetic products. The culture of the strain of the 1st or 2nd passage (example 1) contribute to the nutrient medium, cultured at a temperature of 37-38 degrees Celsius to obtain the biomass of bifidobacteria with the contents of living cells is not less than 1081 ml, dried by spray or freeze drying.

The obtained dry biomass bi is eubacteria Bifidobacterium bifidum 74-22 enter into the composition of the nutrient cream in an amount of not more than 1% of the volume.

Safety: with the introduction of three outbred white mice dose per os microbial culture of strain in an amount of 5×107SOME on the animal, death, deviations in health status of the mice during the observation period is not marked.

Strain Bifidobacterium bifidum No. 244 deposited in GCNM fsri mniam them. Hingamisega Rospotrebnadzor and used to obtain bifidobacteria products.



 

Same patents:

FIELD: chemistry.

SUBSTANCE: Bifidobacterium adolescentis 79-84 strain is isolated from intestinal contents of a healthy adult person and propagates in different culture media with accumulation of production biomass with high concentration of bifidobacteria. The Bifidobacterium adolescentis 79-84 strain has acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms and ferments milk. The strain is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 250.

EFFECT: method enables to use the Bifidobacterium adolescentis 79-84 strain to obtain fermented milk products, fermented and unfermented food products, sour dough, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enables to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers, and also widens the range of similar agents.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: Bifidobacterium adolescentis 79-82 strain is isolated from intestinal contents of a healthy infant and propagates in different culture media with accumulation of production biomass with high concentration of bifidobacteria. The Bifidobacterium adolescentis 79-82 strain has acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms and ferments milk. The strain is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 249.

EFFECT: method enables to use the Bifidobacterium adolescentis 79-82 strain to obtain fermented milk products, fermented and unfermented food products, sour dough, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enables to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers, and also widens the range of similar agents.

2 tbl, 5 ex

FIELD: food industry.

SUBSTANCE: described are version methods for production of recombinant meningococcal Proteins-2086 by way of feed batch fermentation with a bacterial culture with continuous supply of an inducer in a total quantity from approximately 7 g/l to approximately 15 g/l after the threshold parameter has been reached with continuous supply of a carbon source such as supply at a constant rate with subsequent meningococcal protein extraction from the bacterial culture. The cultivation method may be implemented using a bacterial host cell containing an expression vector encoding recombinant protein under control of an induced promoter or by means of a nucleic acid sequence with continuous supply of a carbon source (such as glucose) and an inducer (such as arabinose). Described are compositions for meningococcal protein extraction from the bacterial culture, produced by the said methods and noted for high Protein-2086 density. The protein may be lipidised or non-lipidised.

EFFECT: meningococcal Proteins-2086 yield improvement.

79 cl, 20 dwg, 7 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: strain Pseudomonas species 181a recovered from Karelian breaking rock with using a selective minimal mineral medium containing insoluble calcium phosphate; it is deposited in the State Collection of Pathogenic Microorganisms and Cell Cultures GKPM-Obolensk (Obolensk settlement, Serpukhovsky area of Moscow region) No. B-6646. The strain shows high ability to release phosphates from insoluble mineral raw material; it is active against fungi Fusarium, stimulates plant growth, provides higher crop yield. The strain is non-toxic for plants and may be recommended for making a biophosphoric fertiliser with fungicidal properties on its basis.

EFFECT: invention provides higher efficiency of struggle with Fusarium blight control, and providing higher crop yield.

3 tbl, 6 ex

FIELD: medicine.

SUBSTANCE: strain Acinetobacter species the State Collection of Pathogenic Microorganisms (GKPM) - Obolensk B-6645 showing high ability to release phosphates from insoluble mineral raw material, to stimulate plant growth, to provide higher crop yield; it is active against fungi Fusarium and deposited in the State Collection of Pathogenic Microorganisms and Cell Cultures GKPM-Obolensk (Obolensk settlement, Serpukhovsky area of Moscow region) No. B-6645 and may be used for creating a biophosphoric fertiliser with fungicidal properties.

EFFECT: invention allows inhibiting growth of phytopathogenic fungi Fusarium.

2 tbl, 5 ex

FIELD: food industry.

SUBSTANCE: one proposes a method for enhancement of bifidobacteria viability in the process of storage of a fermented fresh food product containing one or several Bifidobacterium strains. The method involves introduction of gum arabic into the said product before its packaging termination so that final gum arabic concentration in the said food product is from nearly 0.1 to nearly 3 wt %. Additionally one proposes a fermented food product manufactured by the said method.

EFFECT: invention allows to enhance bifidobacteria viability in the fermented product in the storage process providing for an insignificant impact on other lactic bacteria present in the said product.

12 cl, 7 dwg, 4 tbl, 2 ex

FIELD: agriculture.

SUBSTANCE: invention relates to biotechnology. The method includes the selection of strains with signs of growth-initiating and fungistatic action from the roots of wild plants of way barley growing in the range of 1500-2000 m above sea level, and subsequent processing with them of crops of winter wheat. At that wheat is treated in two phases - in spring during aftergrowing - with growth-initiating bacteria, and in the phase of flowering beginning - with fungistatic ones.

EFFECT: invention enables due to alternate use of strains of two kinds of associative bacteria with different properties (growth-initiating and fungistatic), to reduce the incidence of a disease of plants of winter wheat, and increase its productivity.

3 tbl, 3 ex

FIELD: chemistry.

SUBSTANCE: method of producing an Escherichia coli VL-613 based symbiotic preparation involves sowing, culturing bacteria in a liquid medium based on Hottinger broth, concentrating the bacterial suspension and then mixing with a stabiliser, packing and lyophilising the preparation. During the process of culturing Escherichia coli VL-613, redox potential of the bacterial culture is reduced to minus (80-100) mV right after sowing. Before the end of the culturing process, pO2 is kept at 20±5% of saturation of air with oxygen and pH is kept in the 7.0-7.4 range. Glucose is fed in doses until achieving concentration of 0.1-0.2% while limiting growth of Escherichia coli VL-613 with glucose. The culturing process is 4-6 hours long. The preparation contains 80-85% living cells and enables to completely replace synthetic lysine in complete diets when growing broilers.

EFFECT: high quality and stability of the Escherichia coli VL-613 based symbiotic preparation.

3 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: invention relates to method of introduction of protective medium into liquid phase during dispersion of biologically active material. Biologically active material contains liquid phase with active substances in microdrop state, which is stabilised by highly-disperse hydrophobic disconnector with nanosized particles.

EFFECT: increase of dispersity of biologically active materials, containing active substances in liquid phase.

6 tbl, 3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to biotechnology. The method of producing 8-prenylnaringenin in vitro involves: a) providing a first composition containing a culture of Eubacterium limosum or Peptostreptococcus productus bacterial cells, having 5-alkoxyflavonoid-dealkylating activity, and b) bringing a second composition containing 5-alkoxyflavonoids into contact with said first composition to facilitate dealkylation of said 5-alkoxyflavonoids with said bacterial cell culture. Disclosed is a combination for obtaining 8-prenylnaringenin in vitro and use of the culture of Eubacterium limosum or Peptostreptococcus productus bacterial cells, having 5-alkoxyflavonoid-dealkylating activity to obtain 8-prenylnaringenin in vitro. The method of enhancing 5-alkoxyflavonoid-dealkylating activity of the culture of Eubacterium limosum or Peptostreptococcus productus bacterial cells involves a step for inoculating said bacterial cell culture on a medium containing 5-alkoxyflavonoids, and a step for selecting a colony with the highest 5-alkoxyflavonoid-dealkylating activity. The Eubacterium limosum LMG P-23546 strain has 5-alkoxyflavonoid-dealkylating activity and is capable for converting isoxanthohumol to 8-prenylnaringenin.

EFFECT: invention increases efficiency of producing a phytoextractant such as 8-prenylnaringenin.

14 cl, 9 dwg, 4 tbl, 6 ex

FIELD: chemistry.

SUBSTANCE: Bifidobacterium adolescentis 79-84 strain is isolated from intestinal contents of a healthy adult person and propagates in different culture media with accumulation of production biomass with high concentration of bifidobacteria. The Bifidobacterium adolescentis 79-84 strain has acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms and ferments milk. The strain is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 250.

EFFECT: method enables to use the Bifidobacterium adolescentis 79-84 strain to obtain fermented milk products, fermented and unfermented food products, sour dough, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enables to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers, and also widens the range of similar agents.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: Bifidobacterium adolescentis 79-82 strain is isolated from intestinal contents of a healthy infant and propagates in different culture media with accumulation of production biomass with high concentration of bifidobacteria. The Bifidobacterium adolescentis 79-82 strain has acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms and ferments milk. The strain is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 249.

EFFECT: method enables to use the Bifidobacterium adolescentis 79-82 strain to obtain fermented milk products, fermented and unfermented food products, sour dough, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enables to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers, and also widens the range of similar agents.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium bifidum 74-21 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 243 and can be used in producing fermented milk products, food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium bifidum 79-93 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 246 and can be used in producing fermented milk products, food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium adolescentis Vl-1 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 234.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium adolescentis 79-85 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 239.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium bifidum 74-23 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 235.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium longum GV-9 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 227 and can be used in producing fermented milk products, food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium bifidum strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 248.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium adolescentis 79-66 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 232.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: invention relates to food, cosmetic, biotechnology and medical industry. The Bifidobacterium bifidum 74-21 strain, having acid-forming activity, antagonistic activity on pathogenic and opportunistic microorganisms, is deposited in the National Collection of Normal Microflora of the G.N.Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology under registration number 243 and can be used in producing fermented milk products, food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations.

EFFECT: invention enables to obtain fermented milk products, fermented and unfermented food products, sanitary and cosmetic agents, biologically active additives and bacterial preparations, which enable to normalise microbiocenosis of the human body, including gastrointestinal and urogenital tracts, skin and mucous covers.

2 tbl, 5 ex

Up!